---
title: "Executive Summary: RHTP Structure and Rules"
date: 2026-01-15
author: "Syam Adusumilli"
summary: "Executive summary of RHTP Structure and Rules"
tags: ["rural-health", "rhtp", "series-2", "medicaid", "summary"]
showtoc: false
ShowReadingTime: true
ShowBreadCrumbs: true
params:
  is_summary: true
  full_article_url: "../rhtp-structure-and-rules/"
  article_id: "RHTP-2A-Summary"
  collection: "rural-health"
weight: 999
cover:
  image: "cover.webp"
  alt: "Cover image"
  relative: true
build:
  list: never
---

The Rural Health Transformation Program channels $50 billion through a deliberately structured mechanism that makes program success contingent upon correctly understanding its architecture, not merely having worthy intentions. Congress created RHTP in July 2025 after 190 rural hospitals closed permanently between 2010 and 2025, after 700 more facilities entered financial distress, and after rural mortality rates exceeded urban rates by 20 percent for preventable conditions. The investment represents the largest federal commitment to rural health infrastructure in American history. Whether it transforms anything depends on whether states comprehend what the program actually permits, what it explicitly forbids, and what structural constraints shape implementation before any strategy begins.

RHTP operates through cooperative agreements, not traditional grants, a distinction carrying operational consequences. Cooperative agreements involve substantial federal involvement in program activities. The Centers for Medicare and Medicaid Services retains authority to provide ongoing technical assistance, require specific performance metrics, adjust program requirements through administrative action rather than legislative amendment, and review state performance annually for continued funding eligibility. States accepting RHTP funds accept federal oversight as a binding condition. The program distributes $10 billion annually from FY2026 through FY2030 through the newly created Office of Rural Health Transformation, with an additional $12 billion designated for initiatives aligned with Make America Healthy Again priorities. These are not symbolic requirements. MAHA policy alignment influences both initial application scoring and annual re-scoring that determines continued funding eligibility.

The funding formula creates systematic advantages and penalties that states must navigate rather than overcome. **Fifty percent of the annual $10 billion distributes equally among all approved states**, regardless of rural population size, health outcomes, or mortality burden. This produces a baseline of approximately $100 million per state annually, a political compromise ensuring every senator could claim rural health investment for constituents. The remaining fifty percent allocates based on rurality metrics and application quality. States receive credit for land area, low population density, Frontier and Remote Area codes at the most isolated levels, and Rural-Urban Continuum Codes indicating complete rural status without metropolitan adjacency. The formula rewards geographic rurality over health need.

This creates what the University of Pennsylvania Leonard Davis Institute, analyzing allocations for Senator Ron Wyden's office, termed an inverse relationship between health need and funding levels. **Alaska, with 250,000 rural residents, received $272.2 million in FY2026, yielding $368 per rural resident.** Wyoming receives over $400 per capita. Montana receives $425 per capita. Texas, with 4.7 million rural residents (the largest rural population nationally), received $281.3 million (the highest absolute award), producing $60 per rural resident. States with the lowest rural mortality rates receive approximately twice as much funding per rural resident as states with the highest mortality rates. The formula advantages sparse settlement over concentrated need, frontier designation over population health outcomes, geographic isolation over mortality burden.

Whether this represents poor program design or necessary political compromise matters less for implementation than recognizing what the scale penalty means operationally. **Texas cannot accomplish what Alaska can with available funding**, despite Texas facing more hospital closures, more coverage gaps, and more preventable deaths. California's 2.7 million rural residents receive $87 per capita. Mississippi's 1.6 million rural residents receive approximately $119 per capita. Large rural states receive the largest absolute awards but the smallest per-capita investments. States that fail to calibrate strategies to actual available resources per affected population will waste effort on plans that formula constraints render unachievable from inception.

Application requirements shape state strategies before program implementation begins. Only state governments may apply. Each state designates a single lead agency (typically the Department of Health, Medicaid Agency, or combined Health and Human Services entity) responsible for program management and accountable for performance. Applications must document meaningful consultation with State Medicaid Agencies regardless of which entity leads, State Offices of Rural Health, tribal affairs offices in states with federally recognized tribes, and provider and community stakeholders. The CMS evaluates whether stakeholder input meaningfully shaped proposed activities or merely provided political cover for predetermined plans. Applications must include comprehensive transformation plans addressing needs assessment with current data, strategic initiatives in at least three of ten approved use categories with measurable objectives and implementation timelines, performance metrics that are quantifiable and trackable, governance structures explaining coordination mechanisms, and sustainability plans describing how initiatives will continue after FY2030.

**Sustainability is not optional.** States must demonstrate credible plans for post-2030 continuation of initiatives launched with RHTP funds. The requirement forces states to distinguish between activities that can become self-sustaining through payment reform, state general revenue, or partner commitments from activities requiring perpetual federal subsidy. Activities dependent on continued federal support face termination in 2030 regardless of success. The sustainability requirement should influence initial activity selection, with states prioritizing initiatives with realistic transition pathways over programs requiring indefinite external funding.

The ten statutory use categories define what RHTP can fund. Evidence-based prevention and chronic disease management programs must align with MAHA priorities. Provider payments for specified health services are permitted, though not for general operating support. Consumer-facing technology for chronic disease management must be accessible to populations with limited broadband and digital literacy. Training and technical assistance for technology adoption includes both initial training and ongoing support. Clinical workforce recruitment and retention incentives require five-year minimum service commitments to prevent immediate departure after incentive receipt. Information technology advances must address efficiency, cybersecurity, and patient outcomes. Right-sizing healthcare delivery systems means restructuring infrastructure to match community needs, including facility conversions and service line adjustments. Opioid, substance use disorder, and mental health services can expand through workforce development, telehealth, and integrated care models. Value-based care arrangements support transitions from fee-for-service to accountable care organizations, bundled payments, and global budgets. Additional uses promoting sustainable rural health access serve as a catch-all category subject to CMS approval.

What RHTP explicitly prohibits matters as much as what it permits. **RHTP cannot backfill Medicaid cuts.** The same legislation that created RHTP reduced Medicaid spending by $911 billion over ten years. States cannot use RHTP to replace lost Medicaid revenue. New Jersey's application acknowledged this restriction explicitly while noting the state faced $3.3 billion in projected hospital and public health funding cuts. RHTP cannot provide direct operating subsidies to hospitals facing insolvency. States may fund transformation activities that improve financial performance, but not general financial support to keep facilities open. RHTP must fund transformation, not maintenance. Activities must represent new capabilities, expanded services, or system changes. Continuing existing programs without enhancement does not qualify. The distinction between transformation and maintenance is sometimes ambiguous, but CMS guidance emphasizes that RHTP investments should create durable change, not temporarily sustain status quo operations.

The timeline creates competing pressures. **States must obligate FY2026 funds by September 30, 2027.** This two-year obligation deadline measured from the December 29, 2025 award announcement provides approximately 21 months to structure subawards, execute contracts, and initiate activities. The requirement forces action, preventing states from allowing funds to languish while committees deliberate. It also risks hasty decisions, potentially favoring shovel-ready projects over more impactful but slower-developing initiatives. States must balance speed and quality, launching activities quickly enough to meet deadlines while maintaining strategic focus. Unobligated funds return to CMS for reallocation in subsequent fiscal years. States that fail to obligate risk losing not only current-year funding but also credibility for future awards.

Annual re-scoring provides CMS with what Administrator Dr. Mehmet Oz characterized as leverage governors can use to push policies by pointing to the potential loss of millions. The Office of Rural Health Transformation reviews state performance annually against stated metrics, continued MAHA policy alignment, and implementation quality. Clawback triggers include failure to obligate funds within required timelines, substantial deviation from approved transformation plans without CMS approval, material misrepresentation in applications or progress reports, sustained poor performance on stated metrics, and reversal of policy commitments that influenced scoring. Due process provisions require CMS notification of potential clawback, opportunity for state response, and escalation procedures before fund recovery, though the timeline for resolution may exceed the program period.

Republican-led states generally embrace MAHA alignment, viewing policy requirements as congruent with administration priorities they already support. Clawback risk reinforces existing policy direction. Democratic-led states face tension between policy preferences and funding access. Some adopted MAHA-aligned policies despite ideological discomfort, calculating that funding benefits outweigh policy costs. Others declined, accepting lower scores rather than implementing unwanted restrictions. All states must weigh clawback risk in implementation decisions. Activities that underperform metrics or drift from approved plans create vulnerability. The uncertainty of annual re-scoring encourages conservative interpretation of approved uses and careful documentation of compliance.

What RHTP provides is substantial funding for transformation activities (even with per-capita disparities, most states receive $150-280 million annually), federal legitimacy for state priorities that may attract matching investments from foundations and health systems, technical assistance and peer learning opportunities that would otherwise